KRAS and lung carcinoma: Our previous study has demonstrated that the expression of MEN1 is inactivated in approximately 23-27% of lung cancer cases, and this inactivation is correlated with KRAS-mediated DNA methylation at the MEN1 promoter region [9, 18].